Results 11 to 20 of about 22,552 (237)
Transmission of lupus anticoagulant by allogeneic stem cell transplantation
Revista Brasileira de Hematologia e Hemoterapia, 2014 Passive transmission of autoimmune diseases by allogeneic stem cell transplantation is rare and is ascribed to passive transfer of memory B-cells from donor to recipient. We hereby report a case of transmission of an asymptomatic lupus anticoagulant from
Mira Romany Massoud +5 more
doaj +2 more sources
Exogenous Magnesium Chloride Reduces the Activated Partial Thromboplastin Times of Lupus Anticoagulant-Positive Patients. [PDF]
PLoS ONE, 2016 The activated partial thromboplastin time (APTT) assay is a basic hemostatic assay based on the time it takes for clots to form in plasma samples after the addition of calcium chloride. It is used to screen for various coagulation disorders.
Takayoshi Tokutake +10 more
doaj +2 more sources
Antiphospholipid syndrome in lupus retinopathy [PDF]
Clinical Ophthalmology, 2014 Ng Hong-Kee,1,2 Chong Mei-Fong,2 Yaakub Azhany,1 Embong Zunaina1 1Department of Ophthalmology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia; 2Department of Ophthalmology, Hospital Raja Permaisuri Bainun, Ipoh,
Hong-Kee N +3 more
doaj +2 more sources
Lupus anticoagulant and mortality in patients hospitalized for COVID-19 [PDF]
, 2021 Coronavirus disease 2019 (COVID-19) is characterized by a procoagulant state that can lead to fatal thromboembolic events. Several studies have documented a high prevalence of lupus anticoagulant that may at least partially explain the procoagulant ...
Malinverni L. +10 more
core +1 more source
Experimental Biology and Medicine, 1984 Lupus-like anticoagulant (LLAC) is the term used to identify an acquired inhibitor (1) of blood coagulation, first described by Conley and Hartmann in patients with systemic lupus erythematosus (SLE) (2). A circulating “lupus-like” anticoagulant has been detected in 5-10% of all SLE patients.
N, Perico, F, Pusineri, G, Remuzzi
openaire +2 more sources
Anti-phospholipid-antibodies in patients with relapsing polychondritis [PDF]
, 1998 Relapsing polychondritis (RP) is an extremly rare multisystemic disease thought to be of autoimmune origin. In order to assess if RP is associated with anti-phospholipid antibodies (aPL), clinical data and sera of 21 patients with RP were collected in a ...
Schlosser, U. +6 more
core +1 more source
Anaesthesia, 1987 Summary Circulating lupus anticoagulant occurs in 5–37% of all patients with systemic lupus erythematosus. Its occurrence is not restricted to collagen vascular disease states. Lupus anticoagulant causes a prolongation of certain laboratory coagulation studies yet it is associated in vivo with a history of systemic intravascular ...
A M, Malinow +4 more
openaire +4 more sources
Thrombosis Journal, 2006 Background Lupus anticoagulants prolong clotting times in phospholipid-dependent coagulation tests. Lupus Ratio assays are integrated tests for lupus anticoagulants that may be based on APTT, RVVT or dPT clotting times. If a patient is being treated with
Wisløff Finn +3 more
doaj +1 more source
Lupus anticoagulant in systemic lupus erythematosus and its association with complications
, 2022 Background: The anti-phospholipid antibody which can occur secondary to SLE have a broad spectrum of both thrombotic and non-thrombotic manifestations.
Irshad Ali K. M. +7 more
core +1 more source
Arquivos Brasileiros de Cardiologia, 2002 OBJECTIVE: Lupus anticoagulant and anticardiolipin antibodies (aCL) have been associated with thrombosis, recurrent abortion, and thrombocytopenia in patients with systemic lupus erythematosus (SLE), but their relationship with cardiac disease is less ...
Creso Abreu Falcão +4 more
doaj +1 more source